I just bought/sold (Part 8)

Sold remnants of plug, zaptec, kambi. Losses from these, although positions have also become marginal. Impulse buy of Elisa for the cheese account as a cash substitute.

6 Likes

Portfolio maintenance as Nordea lowers its fees this week.

Investment Account: Added 10k + Wärtsilä sale 331 shares @30.30€. Wärtsilä acquired 6&7/2022, return for holding period ~312% + dividends. Replaced with Kesko B 542 shares, Huhtamäki 171 shares and Qt 179 shares.

Company portfolio: Nordea sale 5k shares @15.46€. These were bought 10/2019, return for holding period ~127% + 6*annual dividends. These were sold purely for portfolio rebalancing purposes. Replaced with Kesko B 2163 shares and Schrodinger Inc. 1300 shares. With the remaining funds, the intention is to open a position in Novo Nordisk during the rest of the week.

31 Likes

Last night, Tieto was sold from the portfolio, about 6% of its weight, and at about a 20% loss.

The stock is by no means expensive, but it certainly doesn’t meet my own quality standards, and many more interesting companies are approaching buying prices.

7 Likes

Nordea Stock Savings Week Events:
Additions: Revenio, Novo
Sales: SSAB

6 Likes

I don’t know where I got the idea while lying on this couch. For some reason, however, I just bought 10 more shares of Italian Post, i.e., Poste Italiane. Now I would have 25 of them. For long-term holding, for short-term holding - I don’t know that either. We’ll see.

A bit of a rarer target, or are there other mystery owners here?

11 Likes

Position in Puuilo opened at €13.02/share. I got a really nice discount today, especially when looking at the historical curve and the market recovery (or not?) :+1:

13 Likes

Also bought Puuilo at €13.27. Strong share price reaction to the results. What worries me most, however, are the plans to expand into Sweden.

8 Likes

Added 500 QT units… I bought them for a short hold before earnings, but I changed my mind after the earnings report :face_with_hand_over_mouth: and now it’s a monitoring position (i.e., averaging down).

6 Likes

Qt addition now, previously Revenio, Kempower, Evolution and Remedy.

6 Likes

Canatu 61 pcs @8.18
Have been following with the corner of my eye for a longer time. Don’t know why I bought it just now. FOMO.
Risk stock to accompany Aiforia. Wasn’t supposed to add more risk.
But I just had to…

6 Likes

I would add more Valmet at €26.68, even though I suspect that next year’s earnings forecasts will fall sharply. To round things out, I will also state that I won’t touch Quutti at these prices, even though there seem to be enough buyers for that one too.

I also further reduced Neste at €18.98.

The portfolio’s dividend yield likely improved, but did the total return improve? Time will tell.

13 Likes

I came to open an initial position in Puuilo, this financed by reducing Optomed with a small loss.

The justification is that in my opinion, Puuilo’s dip today is overdone.

18 Likes

Yesterday I was supposed to do a tax-loss selling of DroneShield, but I noticed it was up a good 10%, so I added to it by tripling my original position. The rise seems to continue today as well. The tax-loss selling for this part will remain under consideration.

I made tax-loss sellings of: Fondia, Senes Tech, and Uniqure. There are no others at the moment, so I’ll be paying quite a bit of taxes next year.

Edit: Typo

4 Likes

The end of the year is approaching and Nordea had a stock savings week which enabled cheap portfolio rebalancing. The idea was again to reduce the number of positions and concentrate the portfolio, but in the end, only 1 position was reduced:

Sales:

  • Applied Materials with about 50% profit with a holding period of ~9 months. ASML remained in the portfolio to represent the semiconductor industry, which I feel has stronger moats and growth prospects, so let’s sell something at a profit for once.
  • Mettler-Toledo with about 2% profit and a holding period of just over a year. After owning it for a while, I came to the conclusion that I don’t consider the company’s growth prospects sufficient for myself.
  • Texas Roadhouse sold at about a 10% loss with a holding period of just over a year. I sold this with a bit of a grimace because I consider the company high-quality and its growth prospects good, but if I can buy, for example, Visa or MSCI with a better cash flow yield, then the choice is clear for me.

With the money received from these, I bought the following new positions for the portfolio:

  • Mastercard 5 pcs @ $537.88. There’s not much to justify here, why choose between this or Visa when you can buy both. A high-quality grower with very strong business moats and double-digit growth expected far into the future. Not cheap, but based on historical valuation multiples, it can be bought at a fairly reasonable price now.
  • Adobe 7 pcs @ $340. The company is in an interesting situation; compared to its fundamentals and historical growth, it is very cheap, but sentiment is clearly weighed down by fears of AI and competitor threats. However, I am investing purely based on the company’s very strong fundamentals and growth history. If the fundamentals / growth start to show signs of crumbling, I will sell quickly. If the business continues to move northeast, it will likely remain in the portfolio for a long time.

In addition, additions to the following:

  • MSCI @ $538.22
  • S&P Global @ $491.37
  • Visa @ $352.2
  • Puuilo @ €12.98
  • Canatu @ €8.14
  • Qt Group @ €32.26. Before the addition, Qt was solidly -45% in the red compared to the average price, and the business fundamentals are crumbling before my eyes, so I had promised myself that I would only watch this from the sidelines until the business fundamentals improve. For some reason, these falling knives still attract me so much that I had to lower the average price further. If the business doesn’t look better next year, then in a year, we’ll probably realize even juicier losses.
25 Likes

Reporting briefly on a trade, as things went somewhat as planned.

Added a little under 10% to Puuilo on the earnings drop. 111 pcs, 12.96€. The result was expected, and I guess I could say I also expected the dip. And, of course, on the other hand, feared it. Time will tell if this is a longer-term drop or a dip.

The performance is quite exemplary, but it’s always an unpleasant feeling when expected performance isn’t enough. Often, these earnings reactions have led to a longer decline for a stock. Fortunately, this time we didn’t go downhill despite beating forecasts. Let’s see if its time comes in upcoming quarters.

The company does what it promises. The business is understandable, and I use its services myself. Expansion abroad is a risk, but without risk, there is no return. A stock that is easy to hold and add to if such situations arise. It’s not a cheap stock yet, of course. And hopefully never will be, because then things would likely falter.

10 Likes

Today Optomed addition 500 pcs @3.90. Notes here.

8 Likes

A small addition of Valmet at a price of 26.3€. Now a total of 350 pcs of this treat at an average price of 24.6€.

17 Likes

Purchase: Tekova at 1.350 EUR.

I added 80% of the “CEO’s Christmas money dip” to the OST position and managed to bring the average price of this portfolio down slightly (now 1.43).

The addition to the total position was just under a fifth. Tekova’s weight in all portfolios increased from 4.5% to 5.3% (now the fifth largest holding) and the position is starting to be full. :relieved_face:

2 Likes

Puuilo’s stock is now available for 12.90 euros. Are you coming to get it?

NO. Yes, I am.

So, I reinvested Puuilo’s autumn dividends.

34 Likes

Added Kesko B at a price of €18.30 per share. Utilized Nordea’s Euro Days.

14 Likes